Marshall Wace’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.3K | Sell |
15,062
-181,051
| -92% | -$1.04M | ﹤0.01% | 2413 |
|
|
2025
Q1 | $1.6M | Buy |
196,113
+123,145
| +169% | +$1M | ﹤0.01% | 1468 |
|
|
2024
Q4 | $687K | Buy |
72,968
+52,368
| +254% | +$493K | ﹤0.01% | 1773 |
|
|
2024
Q3 | $220K | Buy |
+20,600
| New | +$220K | ﹤0.01% | 2100 |
|
|
2023
Q4 | – | Sell |
-62,114
| Closed | -$755K | – | 1979 |
|
|
2023
Q3 | $755K | Buy |
+62,114
| New | +$755K | ﹤0.01% | 1332 |
|
|
2021
Q3 | – | Sell |
-16,945
| Closed | -$163K | – | 2534 |
|
|
2021
Q2 | $163K | Buy |
+16,945
| New | +$163K | ﹤0.01% | 1970 |
|
|
2021
Q1 | – | Sell |
-47,199
| Closed | -$1.09M | – | 2246 |
|
|
2020
Q4 | $1.09M | Buy |
+47,199
| New | +$1.09M | 0.01% | 1062 |
|
|
2019
Q3 | – | Sell |
-742,236
| Closed | -$9.26M | – | 1708 |
|
|
2019
Q2 | $9.26M | Buy |
742,236
+573,235
| +339% | +$7.15M | 0.08% | 291 |
|
|
2019
Q1 | $2.3M | Buy |
169,001
+10,911
| +7% | +$148K | 0.02% | 694 |
|
|
2018
Q4 | $1.52M | Sell |
158,090
-1,007,851
| -86% | -$9.66M | 0.02% | 792 |
|
|
2018
Q3 | $14.1M | Buy |
+1,165,941
| New | +$14.1M | 0.12% | 227 |
|
|
2016
Q3 | – | Sell |
-64,107
| Closed | -$350K | – | 1000 |
|
|
2016
Q2 | $350K | Buy |
+64,107
| New | +$350K | ﹤0.01% | 868 |
|
|
2015
Q4 | – | Sell |
-42,224
| Closed | -$591K | – | 1018 |
|
|
2015
Q3 | $591K | Sell |
42,224
-283,044
| -87% | -$3.96M | 0.01% | 713 |
|
|
2015
Q2 | $4.6M | Sell |
325,268
-870,246
| -73% | -$12.3M | 0.06% | 312 |
|
|
2015
Q1 | $13M | Sell |
1,195,514
-73,715
| -6% | -$802K | 0.17% | 155 |
|
|
2014
Q4 | $10.6M | Buy |
+1,269,229
| New | +$10.6M | 0.14% | 186 |
|
|
2014
Q3 | – | Sell |
-339,443
| Closed | -$1.13M | – | 928 |
|
|
2014
Q2 | $1.13M | Buy |
+339,443
| New | +$1.13M | 0.02% | 488 |
|